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Diabetes is characterized by ventilatory depression due to decreased diaphragm (DPH) function. This study investigated the
changes in contractile properties of rat DPH muscles over a time interval encompassing from 4 days to 14 weeks after the onset of
streptozotocin-induced diabetes, with and without insulin treatment for 2 weeks. Maximum tetanic force in intact DPH muscle
strips and recovery from fatiguing stimulation were measured. An early (4-day) depression in contractile function in diabetic DPH
was followed by gradual improvement in muscle function and fatigue recovery (8 weeks). DPH contractile function deteriorated
again at 14 weeks, a process that was completely reversed by insulin treatment. Maximal contractile force and calcium sensitivity
assessed in Triton-skinned DPH ﬁbers showed a similar bimodal pattern and the same beneﬁcial eﬀect of insulin treatment.
While an extensive analysis of the isoforms of the contractile and regulatory proteins was not conducted, Western blot analysis
of tropomyosin suggests that the changes in diabetic DPH response depended, at least in part, on a switch in ﬁber type.
1.Introduction
Increased fatigability of skeletal muscles, characterized by
diﬃculty in squatting and in performing repetitive motions,
is commonly observed in both type I and type II diabetes.
Insulin-dependent diabetes mellitus (IDDM) can also lead
to ventilatory depression and decreased sensitivity to hyper-
capnia [1]. Diaphragm function is a limiting factor for
overall muscle performance, in as much as intense physical
activity causes fatigue of diaphragm muscle even in healthy
individuals of varying ﬁtness levels [2]. As for the cause of
the observed weakness in skeletal and respiratory muscles in
diabetics, it has been generally attributed to the motor and
sensory neuropathy [3] often present in diabetic patients.
Yet,modiﬁcationsinnervefunctionandconductancearenot
consistently observed in these patients, and when they do
appear, they usually do so at a later stage of the disease, thus
implying that diabetic neuropathy cannot be the only cause
of muscular dysfunction [4].
An increased susceptibility to muscle fatigue not only
aﬀects the quality of life but also reinforces the tendency to
physical inactivity typical of the diabetic patient. Decreased
physical activity is very deleterious since even moderate
exercise is beneﬁcial in controlling glycemia in diabetic
patients, limiting the dependence on insulin or oral antidi-
abetic drugs [5]. In recent years, the lack of or a decrease
in physical activity has been considered one of the main
causes, if not a direct trigger, of the increased incidence in
chronic diseases such as diabetes, obesity, hypertension, and
other cardiovascular disorders [6]. Therefore, understanding
factors that in addition to inactivity limit exercise tolerance
in diabetic patients is very important.
Whilst several studies have focused on understanding
how muscle contractility exerts its regulatory role on
glycemia under physiological and diabetic conditions [1–3],
little is known about the cellular mechanisms responsible for
the increased muscle fatigability under diabetic conditions.
Moreover, the majority of the studies performed to date2 Journal of Biomedicine and Biotechnology
have been carried out in hind-limb skeletal muscles or
in cardiac tissue [7–11] whereas scarce attention has been
paid to diaphragm muscle performance. In two previous
studies in diaphragm muscles, Hida et al. [12]r e p o r t e d
a worsening of diaphragm contractile function at 3 and
7 days after streptozotocin administration, while McGuire
and MacDermott [13] reported a compromised contractile
function in diabetic diaphragm muscles at ∼3 months.
To our knowledge, neither of these two studies, nor any
other study to date, has investigated the eﬀects of diabetes
on diaphragm muscles within a sequential time frame
that encompasses acute, steady-state, and chronic eﬀects of
diabetes.
Hence, the main aim of our study was to investigate
changes induced by diabetes in diaphragm contractility
and fatigability in a system in which alterations in nerve
function and conductivity have no direct impact on muscle
performance throughout a broad time span. To achieve our
aim, we used streptozotocin- (STZ-) induced diabetic rats
and age-matched controls over a period ranging from 4 days
to 14 weeks after STZ administration. The eﬀect of insulin
supplementationatalatertimepoint(12weeksSTZ-diabetic
+ 2 weeks of insulin treatment) was also investigated. We
utilized intact diaphragm muscle to concomitantly study
maximal tetanic force produced by the muscles as well as
the contractile response to, and recovery from, fatiguing
stimulation. Skinned ﬁbers were used to assess changes in
calcium sensitivity.
Our data demonstrate that there is an early acute, dele-
terious eﬀect of diabetes on muscle function. This phase is
followed ﬁrst by a gradual improvement in muscle function
reﬂecting a compensatory adaptation that peaks at ∼8w e e k s
and then a marked deterioration in muscle function at 14
weeks after diabetes onset. Two weeks of insulin treatment
at 12 weeks after STZ administration completely reversed
the compromised muscle function observed at 14 weeks. A
similar bimodal pattern of response was also observed in
contractilitystudiesconductedinskinneddiaphragmmuscle
ﬁbers.
These results are discussed in a context of clinical
relevance as the time frame observed (days to weeks in
rats) would be approximately equivalent to changes that
would occur over months to several years of pathology in
humans. Our results suggest that changes in diaphragm
contractile machinery composition and function play a role
in the pathophysiology of respiratory diseases secondary to
diabetes in addition to limiting physical activity in diabetic
patients.
2.MaterialsandMethods
2.1. Animals and Euthanasia. Male Sprague Dawley rats
weighting 180–210g (Harlan Laboratories, Indianapolis, IN)
were sacriﬁced by CO2 inhalation. All procedures were
performed in accordance with the “Guiding Principles in the
Care and Use of Animals” approved by the American Physi-
ological Society and the Animal Protocol Review Committee
of the School of Medicine at CWRU.
2.2. Materials. Insulin and glucose-reader strips were from
Gemco (Hudson, OH). Urine glucose/ketones strips were
from Fisher (Pittsburgh, PA). Streptozotocin and all other
chemicals were of analytical grade (Sigma, St Louis, MO).
2.3. Induction of Diabetes. Rats were randomly divided into
two groups. One group of animals was rendered diabetic by
a single intraperitoneal (ip) injection of 65mg/kg streptozo-
tocin (STZ) in citrate buﬀer (pH 4.0), while control animals
received an equivalent volume of vehicle. Diabetes onset
occurred within 48 hours following STZ administration
and it was determined by the appearance of glucose in the
urine with glucose strips. The diabetic animals and the age-
matchedcontrolsweresacriﬁcedat3-4days(referredtoas4-
dayanimalsforsimplicity),2weeks,4weeks,8weeks,and14
weeksafterSTZadministration.After12weeksfromdiabetes
onset, a subgroup of diabetic animals were placed on daily ip
injection of Ultralente insulin (2 U/50 g body weight). These
animals were sacriﬁced at 14 weeks from diabetes induction
(i.e., after 2 weeks of insulin treatment).
2.4. Intact Muscle Preparation . These experiments were
performed following the protocols established by de Paula
Brotto et al. [14]. After the animals were sacriﬁced, the
intact diaphragm (DPH) muscles were removed and placed
in a dissecting dish containing a modiﬁed Ringer solution
having the following composition (mM): 136.5 NaCl, 5.0
KCl, 1.8 CaCl2,0 . 4N a H 2PO4,0 . 5M g C l 2, 11.9 NaHCO3,
and 10 glucose, pH 7.4, continuously bubbled with 95% O2,
5% CO2,2 5 ◦C, to establish control, normoxic conditions.
DPH muscles were carefully dissected into small muscle
strips measuring 35–40mm in length and less that 1mm
in thickness to favor optimal oxygen diﬀusion throughout
the muscle strips [14]. For each experimental data point 2-
3 strips per animals and 3–6 animals per group (diabetic
or nondiabetic) were utilized, and the obtained data were
averaged. DPH muscle strips were mounted vertically from
the central tendon to the rib cage tissue on a Radnoti
( M o n r o v e a ,C A )s y s t e m .T h em u s c l es u t u r e sw e r ea t t a c h e d
to an isometric force transducer and to a stationary post.
The output of the force transducer was digitized and stored
in a computer for later analysis. The resting tension and the
stimulatory voltage (provided by a Grass digital stimulator)
were adjusted to produce maximal isometric tetanic force
(Tmax). The stimulation pattern for these experiments was
completely automated after the muscles were mounted.
Powerlab/400Eseries(ADInstruments,MountainView,CA)
was used to drive a digital Grass stimulator and Chart for
Windows v4.0.1 (ADInstruments, Mountain View, CA) was
used to collect, digitize, analyze, and store the data to a PC.
2.5. Intermittent Fatiguing Protocols. After Tmax was deter-
mined, the intact DPH strips were allowed to equilibrate for
20 minutes in the Ringer’s solution described above (Equi-
libration Period, Equil in Figure 1). During equilibration,
musclestripswerestimulatedwith100Hz,330mA,500msec
electrical pulse-train administered with a periodicity of 1
minute to generate Tmax. Stimulation during equilibrationJournal of Biomedicine and Biotechnology 3
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Figure 1:OriginalrawdigitaltracingofacontrolDPHmusclestrip
showing our intact contractility protocol. This intact contractility
record shows the last 4 minutes of equilibration (Equil), followed
by the fatiguing stimulation period (Fatigue, 5 minutes) and by the
recovery period. During Equil and Recovery, the muscle strip was
stimulated with tetanic contractions every minute, while during
the fatigue period, the muscles were stimulated every second.
Calibration bars for this speciﬁc experiment are shown. The
horizontal bar denotes time in minutes and the vertical bar the
relative force in mN produced by the preparation.
allowed us to monitor the condition of the muscle and did
not cause measurable fatigue over the 20-minute equilibra-
tion period. Following equilibration, the muscles from the
fatiguegroupweresubjectedtoa5-minutefatiguingprotocol
(Fatiguing Period, Fatigue, Figure 1) consisting of the same
stimulatory pattern administered at a 1-second periodicity.
Thereafter, the periodicity of the stimulus train was returned
to 1-minute intervals and the muscles were allowed to
recover for 30 minutes (Recovery Period, Figure 1). All force
data were normalized to the last tetanic contraction at the
end of the equilibration period and just prior to the start of
the fatiguing protocol (this Tmax = 100%). Absolute force,
normalized per cross-sectional area (in N/cm2), was deter-
mined at the end of the equilibration period as previously
described [14].
2.6. Triton-Skinned Muscle Fibers. Force-versus-pCa rela-
tionships were measured using skinned muscle preparations
dissected from the same DPH strips used for the intact
muscleexperimentsdescribedabove.Thetechniquehasbeen
described in detail elsewhere [15, 16]. In brief, single muscle
ﬁbers were dissected under a microscope and mounted
between an isometric force transducer and a stationary post.
All membranes were removed by exposure to Triton X-
100. Fibers were activated by transferring them to troughs
containing diﬀerent amounts of free calcium. Calcium-
activated force was recorded and normalized to the cross-
sectional area of each ﬁber (in N/cm2) and to the maximal
force produced by each ﬁber (100%, Fmax). The force-versus-
pCa curve for each ﬁber was ﬁt to Boltzmann-Sigmoidal
equationaspreviouslydescribed[15,16].Ca2+sensitivitywas
evaluatedfromCa50 (theCa2+ concentrationproducinghalf-
maximal force). The steepness of the curve was evaluated
from N, the Hill coeﬃcient. After each parameter was
obtained for individual ﬁbers, an average force versus pCa
was calculated. In Table 1, n represents the number of
individual muscle preparations studied while the number in
parenthesis indicates the number of animals from which the
ﬁbers were isolated.
2.7. Western Blot Analysis of Tropomyosin Isoforms. The rat
skeletal muscle SDS-gel samples were resolved by SDS-PAGE
using 14% Laemmli gels with an acrylamide: bisacrylamide
ratio of 180:1 cast using a Bio-Rad mini-Protean II system.
The resolved protein bands were electrically transferred to
nitrocellulose membrane (0.45μm pore size) using a Bio-
Rad semidry transfer apparatus at 5mA/cm2 for 15 minutes.
The membrane was blocked in Tris-buﬀered saline (TBS)
composed of (inmm) 137 NaCl, 5 KCl, and 25 Tris-HCl
(pH 7.4) containing 1% BSA at room temperature for 1
hour and incubated with monoclonal antibody (mAb) CH1
against α-a n dβ-Tm mixed with mAb CG3 against γ-Tm
(provided by Dr. Jim Lin, University of Iowa) [17]i nT B S
containing 0.1% BSA at 4◦C overnight. After three washes
with TBS containing 0.5% Triton X-100 and 0.05% SDS and
two TBS rinses, the membrane was incubated with alkaline
phosphatase-conjugated antimouse IgG second antibody
(Sigma) in TBS containing 0.1% BSA at room temperature
for 1.5 hours. After washes as above, 5-bromo-4-chloro-3-
indolyl phosphate/nitro blue tetrazolium substrate reaction
was carried out as described previously [17] to visualize the
tropomyosin isoforms.
2.8. Statistical Analyses. Values are mean ± SD. Signiﬁcance
was determined by ANOVA followed by either Tukey’s or
Bonferroni’s tests. A value of P < .05 was used as criterion
for statistical signiﬁcance.
3. Results
At the time of sacriﬁce, the level of glycemia was measured
b yg l u c o s e - s t r i pr e a d e ro n2 5 μl of blood and found to be
425 ± 15 versus 88 ± 5mg/100mL for 2-week diabetic and
age-matched control animals, respectively (n = 12 for both
experimental groups, P < .05), not increasing signiﬁcantly
with diabetes progression (e.g., 459 ± 17 versus 93 +
7mg/100mL in 4-week diabetic and age-matched control
animals, respectively (n = 10 for both experimental groups,
P < .05). Rats receiving insulin supplementation presented
ag l y c e m i ao f9 8± 10mg/100mL at the time of sacriﬁce as
comparedto96 ±6and461 ±11mg/100mLinage-matched
control and 14-week diabetic animals, respectively (n = 6f o r
all experimental groups).
Maximal tetanic force (Tmax, normalized to cross-
sectional area in N/cm2 at the end of the equilibration
period) was signiﬁcantly reduced by ∼25% for muscles
isolated from 4-day diabetic animals compared with age-
matched controls (see Table 1). Figure 2(a) illustrates the
response of the 4-day diabetic and age-matched control4 Journal of Biomedicine and Biotechnology
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Figure 2: Temporal adaptation of intact diaphragm (DPH) muscle contractile function in diabetic muscles. All data are presented as the
mean ± SD. (a) Diabetes exerts an acute deleterious eﬀect on DPH contractile function that is reverted with time (b and c) and profoundly
deteriorates with the progression of diabetes (d). After 2 weeks of insulin treatment DPH contractile function signiﬁcantly improves to levels
comparable to control levels (d). In all panels, closed squares show data for control muscles, open circles for diabetic muscles, and the open
triangle represents the diabetic + insulin treatment. ∗ means P < .05. Tmax, number of experiments and statistical details are presented in
Table 1 and methods.
muscles to the fatiguing protocol, with all data normalized to
Tmax for each muscle. While there was an identical decrease
in force in both muscle sets at the end of the fatigue
period to approximately 15% of Tmax, the diabetic muscles
regained force to only 52% of Tmax after 30 minutes of
recovery compared to 80% for the age-matched controls.
The acute eﬀect of diabetes on the recovery of intact
muscle strip function to fatiguing stimulation at 4 days
post streptozotocin administration suggests that acute loss
of insulin signaling renders diaphragm muscle susceptible to
fatigue-induced damage.
We found that the diaphragm muscle of 4-week diabetic
animals may have adapted to the high glucose levels (Table 1,
Figure 2(b)). Tmax was signiﬁcantly increased from the value
in 4-day diabetic animals and was only slightly reduced
(by approximately 10%) from the value in age-matchedJournal of Biomedicine and Biotechnology 5
Table 1: Contractile data from diaphragm of diabetic animals and age-matched controls.
Intact muscles
4 days 4 weeks 8 weeks 14 weeks
Control Diabetic Control Diabetic Control Diabetic Control Diabetic Insulin
n = 7( 4 ) n = 7( 4 ) n = 9( 5 ) n = 8( 4 ) n = 10 (5) n = 10 (5) n = 7( 4 ) n = 7( 4 ) n = 8( 4 )
Tmax (N/cm2)2 5 ±2.21 8 ±1.22 5 .5 ±2.52 2 .9 ±1.5b 24.8 ±2.12 0 ±2.2c 25.3 ±1.11 5 .2 ±1.2d 24.7 ±2.3e
Fatigue (%Tmax)1 6 ±21 7 ±21 0 ±1.51 9 .5 ±1b 12 ±22 4 ±2c 15 ±15 ±1d 20 ±6e
Recovery (%Tmax)8 0 ±55 2 ±6a 62 ±46 5 ±77 0 ±28 8 ±3c 82 ±53 9 ±4d 78 ±6e
Skinned ﬁbers
n = 12(3) n = 9( 3 ) n = 8( 3 ) n = 9( 3 ) n = 12 (4) n = 12 (4)
Fmax (N/cm2)2 3 ±3.11 7 .3 ±2.2∗ 21 ±1.1# 19.5 ±1.8# 14.5 ±2.8∗ 23.8 ±3.8$
pCa50 5.62 ±0.03 5.46 ±0.05∗ 5.70 ±0.12# 5.87 ±0.02# 5.33 ±0.04∗ 5.63 ±0.07$
N 4.45 ±0.22 3.55 ±0.09∗ 3.25 ±0.22# 2.85 ±0.12# 3.35 ±0.20∗ 4.23 ±0.18$
n represents the number of individual muscle preparations studied while the number in parenthesis indicates the number of animals from which the ﬁbers
were isolated.
aTmax and recovery decreased in diabetic muscles (P<. 05)
bTmax decreased and recovery enhanced in diabetic muscles (P<. 05)
cTmax decreased, fatigue reduced and recovery enhanced in diabetic muscles (P<. 05)
dTmax decreased, fatigue increased and recovery decreased in diabetic muscles (P<. 05)
eTmax, fatigue and recovery returned to control levels in diabetic muscles treated with insulin (P<. 05)
∗Fmax reduced, pCa50 reduced (less sensitive) and N decreased (reduced cooperativity) in diabetic ﬁbers (P<. 05)
#Fmax reduced, pCa50 increased (more sensitive) and N decreased (reduced cooperativity) in diabetic ﬁbers (P<. 05)
$Fmax, pCa50 and N returned to control levels in diabetic ﬁbers treated with insulin (P<. 05).
controlmuscles.Unlikethe4-daydiabeticmusclesstripsthat
recovered to a lesser degree than the control muscle strips,
after 4 weeks of diabetes, the muscles from these animals
recovered to the same extend as the age-matched controls.
Interestingly, by 4 weeks, diabetic muscles fatigued signiﬁ-
cantly less than the age-matched controls. The adaptation to
lack of insulin persisted through 8 weeks of diabetes (Table 1,
Figure 2(c)); the diabetic muscles fatigued even less and
recovery from fatiguing stimulation became nearly complete
(88% of Tmax versus 70% in the age-matched controls).
Tmax was further reduced in 8-week diabetic muscles to
approximately20%ofcontrollevels.However,thisseemingly
beneﬁcial adaptive response pattern to fatiguing stimulation
dramatically changed at 14 weeks of diabetes (Table 1,
Figure 2(d)); all three contractile properties signiﬁcantly
decreased when compared to the age-matched controls. By
14 weeks, Tmax was drastically reduced by 40% in diabetic
muscles. We found that these late-stage responses to diabetes
were completely reversed by insulin. When insulin was
administered for two weeks to a set of animals diabetic for 12
weeks,Tmax andforceattheendofthefatiguingandrecovery
periodsallreturnedtothelevelsobservedintheage-matched
controls.
While our intact muscle experiments were able to
reveal clear temporally related phenotypic changes in DPH
muscles from diabetic rats, it is diﬃcult to infer from these
types of experiments any cellular mechanisms that might
account for the observed responses. Triton-skinned muscle
ﬁbers provide a suitable model system to identify speciﬁc
modiﬁcationswithinthecontractilemachinery/proteinsthat
areoccurringatvarioustimesafterstreptozotocintreatment,
particularly considering the temporal changes in Tmax we
detected in our studies. Figure 3 shows the force-versus-pCa
relationships for single skinned muscle ﬁbers from control
(nondiabetic, 3 months of age), 4-day diabetic, 4-week, 8-
weekdiabetic, 14-weekdiabetic,andinsulin-treatedanimals.
At 4 days, the maximum calcium-activated force (Fmax)
signiﬁcantly decreased (by 25%) in a manner that closely
matched the observed reduction in Tmax of intact muscles
(Table 1). In addition, the calcium concentration at which
half-maximal activation was achieved (Ca50) signiﬁcantly
increased, indicating that the ﬁbers had become less sensitive
to calcium (see Table 1, Figure 3). The slope of the curve (N)
alsosigniﬁcantlydecreasedinthe4-daydiabeticﬁbers.Justas
the intact diabetic muscle strips improved their performance
after 4 and 8 weeks of diabetes, single skinned ﬁbers from
diabetic animals recovered to a signiﬁcant extent from the
loss in Fmax (reduced by ∼9% at 4 weeks and 15% at 8 weeks)
while their sensitivity to calcium progressively increased. It is
interestingtonotethatalowerFmax andanincreasedcalcium
sensitivity are observed in slow-twitch, oxidative muscles as
compared to fast-twitch, glycolytic muscles [15, 18]. The
slopeoftheforce-versus-pCacurvescontinuedtobereduced
at these time points. As observed in intact muscles, this
adaptive response was lost at 14 weeks after diabetes onset,
with Fmax and calcium sensitivity decreasing signiﬁcantly.
Muscles from 12-week diabetic animals treated for 2 weeks
with insulin showed a dramatic change in the characteristics
oftheirskinnedﬁbers;thedeteriorationoffunctionobserved
in 14-week diabetic animals was completely reversed with
Fmax,C a 50,a n dN values returning to control levels.
Wesoughttodeterminepotentialmolecularmechanisms
that might explain the adaptive responses of the muscles
to diabetes. The reduction in force (both Tmax and Fmax)
and the increase in calcium sensitivity suggest a change in
ﬁber type. Therefore, we performed Western blot analysis6 Journal of Biomedicine and Biotechnology
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Figure 4: Expression of the slowest Tm isoform occurs in untreated
DPH muscles after 8 weeks of diabetes. Western blot shows the
control and diabetic expression patterns for all three Tm isoforms.
The slowest Tm isoform is only detected in 8-week diabetic muscle
homogenates. See experimental details in Section 2.
of tropomyosin (Tm) isoforms in muscle homogenates from
control and 8-week diabetic rats (Figure 4). We discovered
that while control muscle samples only contained the α-a n d
β-Tm isoforms, 8-week diabetic samples contained the γ-Tm
isoform, an isoform which uniquely appears in slow-twitch
muscles [19].
4. Discussion
To our knowledge, this is the ﬁrst study to investigate
the eﬀects of diabetes induced by STZ on DPH muscles
from mammals during a sequential time frame extending
from 4 days to 14 weeks. Our results clearly demonstrate
that diabetes causes a detrimental acute eﬀect on the
ability of intact DPH muscles to generate maximal tetanic
force (Tmax was decreased by 28%), a condition where the
contractileproteinsaremaximallystimulatedwithsaturating
intracellular calcium. Because the isolated muscle strips used
in this study are directly stimulated, any eﬀect of diabetes on
force generation would be due to a decrease in the force-
generating capability of the contractile apparatus and not
to eﬀects on either nerve activity or the neuromuscular
junction. In fact, when single DPH ﬁbers were isolated from
the same muscles, maximum calcium-activated force (Fmax)
was reduced by essentially the same amount (25%). By 4
weeks after streptozotocin treatment, both Tmax and Fmax
signiﬁcantly recovered but were still less than control values.
It would appear that the contractile proteins are adapting to
the diabetic state. However, by 14 weeks post streptozotocin,
there was a major loss in the force-generating capabilities
of the contractile proteins, both Tmax and Fmax decreased
by approximately 40%. Therefore, the myoﬁlament protein
adaptation is incapable of chronically compensating muscle
function in diabetic conditions. This loss in force is due
to altered glucose metabolism and/or lack of circulating
insulin since DPH muscles from 12-week diabetic animals
supplemented with insulin for 2 weeks presented a complete
reversal of this detrimental eﬀect. A recent study in muscle-
speciﬁc G protein α-subunit (Gsα) knockout mice [20]
showed that this disruption of insulin signaling in skeletal
muscles resulted in an adaptive ﬁber-type switch toward
increased slow ﬁber contents in the absence of hyper-
glycemia. The results in our present study are consistent
with this observation and further demonstrate a beneﬁcial
eﬀect of the increase in slow ﬁbers on compensating fatigue
tolerance in diabetes.
Diabetic patients exhibit increased muscle fatigability
and diﬃculty in squatting and in performing repetitive
motions. Therefore, we stimulated the isolated DPH muscle
strips from control and diabetic animals with a pattern
of fatiguing stimulation to determine how they respond
to, and recover from, the stress of increased activity.
Both slow- and fast-twitch muscle ﬁbers typically respond
to fatiguing stimulation with a decrease in tetanic force
that will recover to a varying degree upon cessation of
stimulation [21]. Loss of force during the fatigue period
can be due to (1) loss of the maximum force-producing
capability of the contractile apparatus, (2) a decrease in
the calcium sensitivity of the contractile apparatus, (3)
disruption of the excitation-contraction coupling process
that provides calcium to the contractile proteins, and (4)
depletion of energy substrates, including ATP, creatine
phosphate, and glucose. We found that after 4 days of
diabetes, Tmax decreases to the same extent after the
fatiguing period when compared to age-matched control
muscles. However, the fact that Tmax does not recover to
the same extent in diabetic as in control muscles signiﬁes
that one or more of these eﬀects of fatiguing stimulation
is/are irreversible in the diabetic muscles, at least at this
time point. Irreversible damage of fatiguing stimulation toJournal of Biomedicine and Biotechnology 7
DPH muscle can account not only for possible respiratory
complications but also for the increased muscle fatigue
and propensity to inactivity experienced by many diabetic
patients.
An adaptation to diabetes similar in time course to that
observed forTmax and Fmax wasalsoobserved in the response
of the muscles to fatiguing stimulation. After 4 weeks of
diabetes, the intact muscles fatigued less and recovered to
the same extent as age-matched controls. After 8 weeks of
diabetes, the fatigue response was signiﬁcantly less than at
4 weeks of diabetes and the recovery was now signiﬁcantly
greater in the diabetic animals. The observation that the
calcium sensitivity of the skinned ﬁbers at both 4 and 8
weeks after diabetes was greater than control may at least
partially account for this observation; even if the excitation-
contraction coupling (ECC) process is permanently com-
promised by fatiguing stimulation, the increased calcium
sensitivity of the ﬁbers would limit the loss of tetanic force
at the end of the recovery period. The potential beneﬁcial
eﬀects of this adaptation are lost by 14 weeks post diabetes.
At this time, corresponding to years of diabetes in humans,
intact ﬁbers fatigue to only 5% of the maximal Tmax and the
recovery is only to approximately 40%. The corresponding
loss of calcium sensitivity of the contractile proteins and
the loss of cooperativity between the contractile proteins (as
reﬂected in the decreased slope of the force-versus-calcium
curve)cancontributetothisresponse.Ourfunctionaldataat
theextremeperiodsstudiedhere(4daysand14weeks)arein
complete agreement with the ﬁndings of Hida et al. [12]a n d
McGuire and MacDermott [13], respectively. Interestingly,
allofthesedetrimentaleﬀectsofdiabetesonmusclefunction
were completely reversed by 2 weeks of insulin treatment
in our study, demonstrating the fundamental role of insulin
signaling in maintaining skeletal muscle function. Whereas
these beneﬁts were concurrent with renormalized glycemia,
which minimizes protein glycation and AGEs generation,
the role of insulin-mediated cell signaling warrants further
investigation.
Based on data available in the literature and on the
progressive decrease in absolute force developed by DPH
muscles from diabetic rats, it is conceivable that part of the
process activated by diabetes involves alterations/adaptations
in the contractile proteins. Contractile force is directly
related to intracellular Ca2+ levels. The more calcium is
releasedfromthesarcoplasmicreticulum(SR),thehigherthe
contractile force becomes due to the saturation of contractile
proteins by Ca2+ (see Figure 3). It is evident from this
relationship that the contractile force produced at higher
frequencies of stimulation mirrors the events associated with
the contractile proteins, while SR-related events are better
reﬂected at the ascending part of the curve [22]. Because
our studies were conducted under conditions where the
frequency of stimulation used produced maximal tetanic
force (Tmax), we can postulate that the adaptation observed
in DPH muscles from diabetic rats is probably intrinsic to
the contractile proteins although other steps of the ECC
p r o c e s sc a n n o tb ec o m p l e t e l yr u l e do u tb yo u rp r e s e n ts t u d y .
This is supported by our studies on skinned ﬁbers. The
adaptive response during weeks 4–8 of diabetes is similar
to what one would ﬁnd if the ﬁbers with the diaphragm
were switching from primarily fast-twitch to primarily slow-
twitch, Fmax would decrease and the ﬁbers would become
more sensitive to calcium [23]. We tested this hypothesis
by measuring the isoforms of Tm that were present in
control and diabetic muscles. α-a n dβ-Tm isoforms are
characteristic of fast-twitch muscles and we found only
these isoforms in the control muscles. In contrast, 8-week
diabetic muscle samples in addition to the α-a n dβ-
Tm isoforms contained the γ-Tm isoform, which is only
found in slow-twitch muscle ﬁbers [19] .W h i l et h i si sn o t
a thorough analysis of isoforms changes in the contractile
and regulatory proteins under these conditions, the studies
of Zhi et al. [17] suggest that an increase in the γ-Tm
isoform would be accompanied by an increase in the myosin
heavy chain isoforms I and IIa, a decrease in the myosin
heavy chain isoforms IIb and IIx, and a switch from fast
to slow isoforms of Troponin I and Troponin T. Therefore,
it would appear that at least part of the compensation
observed at 4 and 8 weeks of diabetes is due to a certain
degree of ﬁber-type switching. While this adaptation is
potentially beneﬁcial in that it can help the diaphragm
by functional compensation, it is incapable of sustaining
diaphragm function while diabetic lesion progresses, which
will ultimately cause an uncompensated loss of function.
The ﬁber-type switching, however, may represent only one
aspect of the decreasing compensatory adaptation over time.
Changes in energy metabolism, calcium cycling within the
muscle ﬁbers, diabetes progression, increased formation of
reactive oxygen species, and AGEs products can all constitute
causes or concauses of the observed phenomenon. It is very
encouraging to note, however, that the loss of function
can be fully reversed by insulin treatment. This ﬁnding
is in agreement with the clinical observation that diabetic
patients report fewer complaints about muscle fatigue
when on insulin therapy and glucose levels are normalized
[24].
5. Conclusions
Inconclusion,ourstudyistheﬁrsttoindicatetheoccurrence
of signiﬁcant temporal adaptations in diaphragm contrac-
tility in type I diabetic animals. This change is triphasic,
in that an initial deterioration is followed by a marked
amelioration and by a tardy stage in which muscle function
is again severely impaired. Our studies in skinned muscle
ﬁbers suggest that the cellular site of perturbation in diabetic
muscle ﬁbers is the contractile machinery/proteins. While
our inaugural biochemical studies indicate the appearance
of a slow tropomyosin isoform, additional biochemical
approaches are required to more precisely determine the cel-
lular basis of these changes in diabetic diaphragm as well as
their pathophysiological signiﬁcance. Protein modiﬁcation
might be an adaptive response to the diabetic milieu stress,
while insulin therapy and glucose normalization might
protect the contractile machinery against the deleterious
eﬀects of the oxidative and inﬂammatory milieu induced by
diabetes.8 Journal of Biomedicine and Biotechnology
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